Lansen Pharmaceutical Holdings Limited has announced that Mr. Hou Song (Mr. Hou) has resigned as an executive director of Lansen, a member of the executive committee and as the Chief Financial Officer of the Lansen group with effect on 20 October 2018 due to his decision to pursue his other career opportunities. Mr. Hou has confirmed that he has no disagreement with the board of Lansen and there is no matter that needs to be bought to the attention of the shareholders of Lansen in relation to his resignation.